Molecular Formula: C17H13N3Na2O6
Molar mass: 401.28 g/mol
Product categories of Balsalazide disodium (82101-18-6): API; digestive system drugs; Pharmaceutical and Biological Chemica
Structure of Balsalazide disodium (82101-18-6):

H-Bond Donor: 2
H-Bond Acceptor: 8
IUPAC Name: Disodium(3Z)-3-[[4-[(3-oxido-3-oxopropyl)carbamoyl]phenyl]hydrazinylidene]-6-oxocyclohexa-1,4-diene-1-carboxylate
Canonical SMILES: C1=CC(=CC=C1C(=O)NCCC(=O)[O-])NN=C2C=CC(=O)C(=C2)C(=O)[O-].[Na+].[Na+]
Isomeric SMILES: C1=CC(=CC=C1C(=O)NCCC(=O)[O-])N/N=C\2/C=CC(=O)C(=C2)C(=O)[O-].[Na+].[Na+]
InChI: InChI=1S/C17H15N3O6.2Na/c21-14-6-5-12(9-13(14)17(25)26)20-19-11-3-1-10(2-4-11)16(24)18-8-7-15(22)23;;/h1-6,9,19H,7-8H2,(H,18,24)(H,22,23)(H,25,26);;/q;2*+1/p-2/b20-12-;; 
InChIKey: GNDOBTSWAIDUCE-OVVGNOJWSA-L

 Balsalazide disodium (82101-18-6) is an anti-inflammatory drug used in the treatment of inflammatory bowel disease.

 Balsalazide disodium (82101-18-6) also can be called Colazal ; BX 661A ; Benzoic acid, 5-((4-(((2-carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxy-, disodium ; 5-[(E)-{4-[(2-carboxylatoéthyl)carbamoyl]phényl}diazényl]-2-hydroxybenzoate de disodium .It is usually administered as the disodium salt of Balsalazide . Balsalazide is sold in generic form in the US by several generic manufacturers, and also sold under the name "Colazal" in the US and "Colazide" in the UK.Its advantage over that drug in the treatment of Ulcerative colitis is believed to be the delivery of the active agent past the small intestine to the large intestine, the active site of ulcerative colitis.